Jane Vella-Brincat

637 total citations
18 papers, 410 citations indexed

About

Jane Vella-Brincat is a scholar working on Pharmacology, Psychiatry and Mental health and Surgery. According to data from OpenAlex, Jane Vella-Brincat has authored 18 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Psychiatry and Mental health and 4 papers in Surgery. Recurrent topics in Jane Vella-Brincat's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Nausea and vomiting management (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). Jane Vella-Brincat is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Nausea and vomiting management (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). Jane Vella-Brincat collaborates with scholars based in New Zealand, Australia and United States. Jane Vella-Brincat's co-authors include A. D. Macleod, Evan J. Begg, Carl M. J. Kirkpatrick, Stephen T. Chambers, Mei Zhang, Kate Gallagher, Paul K. L. Chin, Brian A. Darlow, Adrienne Lynn and Murray L. Barclay and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, British Journal of Clinical Pharmacology and Journal of Pain and Symptom Management.

In The Last Decade

Jane Vella-Brincat

17 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Vella-Brincat New Zealand 11 134 91 86 84 57 18 410
Frank Breve United States 14 76 0.6× 82 0.9× 109 1.3× 38 0.5× 48 0.8× 42 558
Pamela D. Reiter United States 16 139 1.0× 66 0.7× 61 0.7× 225 2.7× 70 1.2× 45 617
Chi D. Hornik United States 10 51 0.4× 45 0.5× 57 0.7× 170 2.0× 49 0.9× 35 401
Aaron Schneir United States 17 273 2.0× 93 1.0× 222 2.6× 31 0.4× 74 1.3× 43 1.1k
Sascha Tafelski Germany 17 125 0.9× 69 0.8× 63 0.7× 30 0.4× 145 2.5× 64 765
Dominique Vodovar France 15 104 0.8× 34 0.4× 73 0.8× 47 0.6× 76 1.3× 73 791
Allison Forni United States 6 84 0.6× 37 0.4× 20 0.2× 49 0.6× 34 0.6× 8 369
Mojdeh S. Heavner United States 12 70 0.5× 55 0.6× 31 0.4× 19 0.2× 45 0.8× 59 491
Bradley Power Australia 12 143 1.1× 43 0.5× 89 1.0× 30 0.4× 161 2.8× 22 758
Christopher Hoyte United States 15 346 2.6× 53 0.6× 118 1.4× 122 1.5× 90 1.6× 63 1.1k

Countries citing papers authored by Jane Vella-Brincat

Since Specialization
Citations

This map shows the geographic impact of Jane Vella-Brincat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Vella-Brincat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Vella-Brincat more than expected).

Fields of papers citing papers by Jane Vella-Brincat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Vella-Brincat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Vella-Brincat. The network helps show where Jane Vella-Brincat may publish in the future.

Co-authorship network of co-authors of Jane Vella-Brincat

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Vella-Brincat. A scholar is included among the top collaborators of Jane Vella-Brincat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Vella-Brincat. Jane Vella-Brincat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ma, Yi, et al.. (2020). Patient characteristics, treatment outcomes and rehabilitation practices for patients admitted with hip fractures using multiple data set analysis.. PubMed. 133(1526). 31–44.
2.
Vella-Brincat, Jane, et al.. (2019). Three-month use of idarucizumab at Christchurch Hospital through the emergency department and MedChartTM.. PubMed. 132(1499). 18–22. 3 indexed citations
3.
Chin, Paul K. L., et al.. (2014). Gentamicin and Renal Function. Therapeutic Drug Monitoring. 37(1). 98–103. 13 indexed citations
4.
Chin, Paul K. L., Jane Vella-Brincat, S. Walker, Murray L. Barclay, & Evan J. Begg. (2013). Dosing of dabigatran etexilate in relation to renal function and drug interactions at a tertiary hospital. Internal Medicine Journal. 43(7). 778–783. 10 indexed citations
5.
Vella-Brincat, Jane, et al.. (2012). Is it NICE to monitor lithium routinely?. PubMed. 125(1355). 50–4. 2 indexed citations
6.
Chin, Paul K. L., Jane Vella-Brincat, Murray L. Barclay, & Evan J. Begg. (2012). Perspective on dabigatran etexilate dosing: why not follow standard pharmacological principles?. British Journal of Clinical Pharmacology. 74(5). 734–740. 14 indexed citations
7.
Currow, David C., Jane Vella-Brincat, Belinda Fazekas, et al.. (2012). Pharmacovigilance in Hospice/Palliative Care: Rapid Report of Net Clinical Effect of Metoclopramide. Journal of Palliative Medicine. 15(10). 1071–1075. 16 indexed citations
8.
Macleod, A. D. & Jane Vella-Brincat. (2012). Cachexia, depression, and sickness behaviour. Progress in Palliative Care. 20(3). 163–168. 1 indexed citations
9.
Vella-Brincat, Jane, et al.. (2011). Are Gentamicin and/or Vancomycin Associated with Ototoxicity in the Neonate? A Retrospective Audit. Neonatology. 100(2). 186–193. 33 indexed citations
10.
Vella-Brincat, Jane, et al.. (2011). The Pharmacokinetics and Pharmacogenetics of the Antiemetic Cyclizine in Palliative Care Patients. Journal of Pain and Symptom Management. 43(3). 540–548. 6 indexed citations
11.
Jensen, Berit Packert, Jane Vella-Brincat, & Evan J. Begg. (2011). Quantification of cyclizine and norcyclizine in human plasma by liquid chromatography–tandem mass spectrometry (LC–MS/MS). Journal of Chromatography B. 879(9-10). 605–609. 8 indexed citations
12.
Begg, Evan J., et al.. (2009). Eight years' experience of an extended-interval dosing protocol for gentamicin in neonates. Journal of Antimicrobial Chemotherapy. 63(5). 1043–1049. 21 indexed citations
13.
Vella-Brincat, Jane, et al.. (2008). Prescribing and Monitoring Clozapine in Christchurch. Australasian Psychiatry. 16(4). 263–267. 13 indexed citations
14.
Vella-Brincat, Jane, Evan J. Begg, Carl M. J. Kirkpatrick, et al.. (2007). Protein binding of cefazolin is saturable in vivo both between and within patients. British Journal of Clinical Pharmacology. 63(6). 753–757. 64 indexed citations
15.
Vella-Brincat, Jane & A. D. Macleod. (2007). Adverse Effects of Opioids on the Central Nervous Systems of Palliative Care Patients. Journal of Pain & Palliative Care Pharmacotherapy. 21(1). 15–25. 11 indexed citations
16.
Vella-Brincat, Jane & A. D. Macleod. (2007). Adverse Effects of Opioids on the Central Nervous Systems of Palliative Care Patients. Journal of Pain & Palliative Care Pharmacotherapy. 21(1). 15–25. 93 indexed citations
17.
Vella-Brincat, Jane. (2004). Stability of benzylpenicillin during continuous home intravenous therapy. Journal of Antimicrobial Chemotherapy. 53(4). 675–677. 37 indexed citations
18.
Vella-Brincat, Jane & A. D. Macleod. (2004). Haloperidol in palliative care. Palliative Medicine. 18(3). 195–201. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Breve Breakdown of academic impact, for papers by Pamela D. Reiter Breakdown of academic impact, for papers by Chi D. Hornik Breakdown of academic impact, for papers by Aaron Schneir Breakdown of academic impact, for papers by Sascha Tafelski Breakdown of academic impact, for papers by Dominique Vodovar Breakdown of academic impact, for papers by Allison Forni Breakdown of academic impact, for papers by Mojdeh S. Heavner Breakdown of academic impact, for papers by Bradley Power Breakdown of academic impact, for papers by Christopher Hoyte
Rankless by CCL
2026